Supra Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.57 M
as on 24-10-2024
- Revenue 29.96%
(FY 2023)
- Profit -32.76%
(FY 2023)
- Ebitda -31.12%
(FY 2023)
- Net Worth -43.16%
(FY 2023)
- Total Assets 22.08%
(FY 2023)
About Supra Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.57 M.
Prabhakar Arikirevula and Ramaa Arikirevula serve as directors at the Company.
- CIN/LLPIN
U24233TG2009PTC063559
- Company No.
063559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Supra Sciences Private Limited offer?
Supra Sciences Private Limited offers a wide range of products and services, including Natural and Synthetic Resins, Resins, Chemical Reagents & Catalysts, Halogenating Agent, Chemical Compound, Cresylic Acid, Chemical Intermediates, Sulfonic Acid, Organic Compounds, Polystyrene Resin.
Who are the key members and board of directors at Supra Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhakar Arikirevula  | Director | 06-May-2009 | Current |
Ramaa Arikirevula  | Additional Director | 12-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Supra Sciences.
Supra Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.96% increase. The company also saw a substantial fall in profitability, with a 32.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supra Sciences?
In 2023, Supra Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Jul 2024 | ₹5.57 M | Open |
How Many Employees Work at Supra Sciences?
Unlock and access historical data on people associated with Supra Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supra Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supra Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
